Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
about
A microarray configuration to quantify expression levels and relative abundance of splice variants.A Review on Potential Mechanisms of Terminalia chebula in Alzheimer's DiseaseDifferential localization of acetylcholinesterase in neuronal and non-neuronal cellsAcetylcholinesterase as a biomarker in environmental and occupational medicine: new insights and future perspectivesAltered levels of acetylcholinesterase in Alzheimer plasma.Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.Adaptive alternative splicing correlates with less environmental risk of parkinsonism.Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.Nonenzymatic functions of acetylcholinesterase splice variants in the developmental neurotoxicity of organophosphates: chlorpyrifos, chlorpyrifos oxon, and diazinon.Rivastigmine for subcortical vascular dementia.Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation.Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.Rivastigmine in the treatment of Alzheimer's disease: an update.Acetylcholinesterase and apoptosis. A novel perspective for an old enzyme.Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath.The attenuating effects of 1,2,3,4,6 penta-O-galloyl-β-d-glucose on inflammatory cytokines release from activated BV-2 microglial cellsNeuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity.Interaction of acetylcholinesterase with neurexin-1β regulates glutamatergic synaptic stability in hippocampal neurons.Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management.Acetylcholinesterase (AChE) is an important link in the apoptotic pathway induced by hyperglycemia in Y79 retinoblastoma cell line.Rivastigmine in the treatment of patients with Alzheimer's diseaseIt all starts at the ends: multifaceted involvement of C- and N-terminally modified cholinesterases in Alzheimer's disease.Hydrogen peroxide modifies both activity and isoforms of acetylcholinesterase in human neuroblastoma SH-SY5Y cells.Alterations of acetylcholinesterase activity after traumatic brain injury in rats.Acetylcholinesterase protein level is preserved in the Alzheimer's brain.Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.Low dose, high dose, or no dose: better prescribing of cholinesterase inhibitors for Alzheimer's disease.
P2860
Q24797945-F426A25F-1BDC-44BF-BFAE-270A33FA8DA2Q26864964-A948CD33-AE01-4B93-A6D9-3720854C037EQ28580850-8D0ACC97-1748-4CA5-97B7-2BDDC5309FBDQ28691738-A7C1BD2B-8964-42B7-B6C7-269E23EA6E58Q33592024-975B6726-EE8E-4775-8DA7-5C3D8AEC86D5Q33715239-54823B05-C735-441C-93BA-1E0AA05AAAA0Q34229198-D9CB7ED8-A230-476A-85CE-2619143FA221Q34804797-F9C13EF0-8CC8-4F6D-A0D3-842AF2009E27Q35636257-C98B552D-DDB7-4DC4-9251-98C4236167BEQ36153360-23241C90-A823-4529-B712-E96E1969805AQ36540223-2B4EB726-4D5A-44F0-B6A3-2C43286B3964Q36846711-B6785A52-352E-48AE-A02D-F390D9C067A4Q37017260-0AC46F26-776B-4D8E-8BE0-8445ED4C6CF3Q37060537-C9900E3F-C869-4AC9-AC51-B11F39970156Q37104891-71E2F6D6-0610-464A-8297-C4D3701499ACQ37237443-63F95F58-04E1-43ED-809F-7FEFADD404B0Q37398055-B67AB3E6-D0A9-48F4-B25E-3ADEA8B8EDEDQ37701836-762784BC-AE46-4C51-9022-23DA460B908EQ38132755-E38B5EAB-4B9E-45B7-9F3D-05E766E2B93CQ38217301-5B0C219C-E261-4195-9811-9F0A7B7270E8Q38599650-B2010C02-15EB-4A38-9AD6-185849E68046Q38899961-E9DF1626-C0AA-488E-AEA5-5523A591C6F1Q39333575-E5762FDC-7BA5-41E9-863A-A21A728ECF3CQ42126217-3C00188A-8B11-42D1-A6F7-3EA824C6D336Q42149357-F05F1965-8E68-466D-94EF-9F33724E6034Q42178155-3C47ECEF-6A0B-45B6-A1F2-475B6BBDB8A1Q42519276-6300D465-F236-4495-A175-1618C2128D26Q45310728-053011BA-70D7-4703-90C3-768F729BE6ADQ48190297-F0D2BDD9-786A-4833-AE02-902E8D9FBB5DQ53337462-A3A41EB5-8E0C-4642-BDE5-31CD578C5332
P2860
Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Long-lasting acetylcholinester ...... Alzheimer's disease patients.
@en
Long-lasting acetylcholinester ...... Alzheimer's disease patients.
@nl
type
label
Long-lasting acetylcholinester ...... Alzheimer's disease patients.
@en
Long-lasting acetylcholinester ...... Alzheimer's disease patients.
@nl
prefLabel
Long-lasting acetylcholinester ...... Alzheimer's disease patients.
@en
Long-lasting acetylcholinester ...... Alzheimer's disease patients.
@nl
P2093
P50
P1476
Long-lasting acetylcholinester ...... d Alzheimer's disease patients
@en
P2093
C Flores-Flores
E Hellström-Lindahl
P2860
P304
P356
10.1046/J.1471-4159.2003.02230.X
P407
P577
2004-03-01T00:00:00Z